He also served as General Counsel and Secretary of AVEO Pharmaceuticals, and as Director of Corporate Legal Affairs at Oscient Pharmaceuticals Corporation. Prior to this, he served as Vice President of Legal Affairs and a member of the Management Committee at Flexion Therapeutics. Previously, Joseph held several positions at AMAG Pharmaceuticals, including most recently serving as its Executive Vice President, Chief Business Officer, and General Counsel & Corporate Secretary. Joseph has over 20 years of experience in the biopharmaceutical industry, including experience providing companies with strategic guidance on initial public offerings, equity and debt financings, mergers, acquisitions and divestitures and complex collaboration arrangements. Howard earned his BS from Lehigh University, his MD from Drexel University College of Medicine, and his MBA from La Salle University. Franklin served as a general surgeon in private practice. Prior accomplishments include supporting the regulatory submission and FDA approval of PLENVU ®, Dex圜u ®, and Solesta ®. Previously, he held leadership roles within early-stage biotechnology companies as well as large pharmaceutical companies, including Icon Bioscience, Oceana Therapeutics, The Medicines Company, and Esprit Pharma. He most recently served as Chief Medical Officer at Salix Pharmaceuticals, where he provided leadership and expertise to program teams focused on the development of GI therapeutics, including amiselimod, next generation Xifaxan ® formulations, ENVIVE ™, and other GI and microbiome focused programs. Franklin has more than 20 years of experience as a general surgeon and biopharmaceutical executive, with deep expertise spanning clinical development, regulatory strategy, medical affairs, and product commercialization. Her accomplishments include supporting the successful development of Feraheme ®, Inbrija ®, and Vivitrol ®.Īlka earned a bachelor’s degree in Toxicology and Pharmacology and a PhD in Toxicology from the School of Pharmacy, University of London, UK.ĭr. Prior to this, she held increasing responsibilities at CombinatoRx, Synta Pharmaceuticals, Alkermes and GSK. ![]() Previously, she held leadership roles at Akashi Therapeutics, Warp Drive Bio, and AMAG Pharmaceuticals. Batycky most recently served as Chief Development Officer at Ohana Biosciences, where she oversaw regulatory, manufacturing, quality and clinical operations. She has led development teams across a broad range of therapeutic areas including oncology, CNS disorders, inflammatory diseases and reproductive health, utilizing multiple modalities including small molecules, biologics, devices and combination products. Batycky has more than 20 years of international biopharmaceutical industry experience, spanning from early discovery to product approval. He is also a Chartered Financial Analyst (CFA) charterholder.ĭr. Marc received his master’s degree in Public Policy from Harvard University and bachelor’s degree in Biology from the University of Pennsylvania. Marc began his career in management consulting, first at Mercer Management Consulting, and then as a founding partner of Northbridge Consulting. Prior to Alkermes, he worked in business development at Genetics Institute (now Pfizer). Prior to Dyax, he held business development and management roles at Alkermes, where he initiated and led the development program for Vivitrol ®. (now Takeda), where he led the development of Kalbitor ®. Before founding Akashi, he served in various leadership positions across several biotechnology companies, including Senior Vice President of Manufacturing, Process and Commercial Operations at Dyax Corp. ![]() Prior to Guide Therapeutics, Marc was the Chief Executive Officer of NED Biosystems and co-founder and Chief Executive Officer of Akashi Therapeutics. Prior to joining Finch, Marc consulted as the Head of Business Development for Guide Therapeutics, which was acquired by Beam Therapeutics in 2021. Marc is a seasoned biopharmaceutical executive with more than 20 years of experience building and leading companies and critical business functions including operations, business development, program management, and manufacturing.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |